Frank della Fera

Frank della Fera

Director/Board Member at LSL PHARMA GROUP INC.

Net worth: 383 979 $ as of 2024-04-29

66 year
Health Technology
Consumer Services

Profile

Frank J.
della Fera
is the President & Chief Executive Officer at Fera Pharmaceuticals LLC, a Director at LSL Pharma Group, Inc., and a former Vice President-Sales & Marketing at Eon Labs, Inc. He previously held positions as Sales Director at Dura Pharmaceuticals, Inc., Director at Grenville Baker Boys & Girls Club, Inc., Principal at Eli Lilly & Co., Vice President-Sales & Marketing at Sandoz, Inc., and Principal at Ben Venue Laboratories, Inc. He received his undergraduate degree from St. John's University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-04-22 1,292,857 ( 1.57% ) 383 979 $ 2024-04-29

Frank della Fera active positions

CompaniesPositionStart
LSL PHARMA GROUP INC. Director/Board Member -
Sales & Marketing -
Chief Executive Officer -
All active positions of Frank della Fera

Former positions of Frank della Fera

CompaniesPositionEnd
Grenville Baker Boys & Girls Club, Inc. Director/Board Member -
Chief Executive Officer -
Corporate Officer/Principal -
ELI LILLY AND COMPANY Corporate Officer/Principal -
Sales & Marketing -
See the detail of Frank della Fera's experience

Training of Frank della Fera

St. John's University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Frank della Fera's experience

Connections

6

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
ELI LILLY AND COMPANY

Health Technology

LSL PHARMA GROUP INC.

Health Technology

Private companies6

Health Technology

Health Technology

Health Technology

Health Technology

Grenville Baker Boys & Girls Club, Inc.

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Frank della Fera
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW